StockData
InMed Pharmaceuticals Inc. logo

InMed Pharmaceuticals Inc. (INM) stock

INMNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as MTRI
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 3, 2026Score 4/30
$1.37+0.05 (+3.44%)

Close on Oct 19, 2026Market cap $83.97MP/E –Yield –

InMed Pharmaceuticals price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

InMed Pharmaceuticals's price to sales ratio was 0.4× on Apr 30, 2026, against 0.4× a year earlier. Over the last 4 years it ranged from 0.2× to 9.3×, with a median of 0.6×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Apr 30, 20260.4×−0.1
2025Dec 31, 20250.6×−0.1
2024Dec 31, 20240.6×+0.3
2023Dec 29, 20230.3×−1.0
2022Dec 30, 20221.3×−5.1
2021Oct 29, 20216.4×–

More InMed Pharmaceuticals figures

See a number that looks wrong?